Technical Analysis for CTLT - Catalent, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.20% | |
| Gapped Down | Weakness | 0.20% | |
| 20 DMA Resistance | Bearish | -0.17% | |
| 20 DMA Resistance | Bearish | 0.15% | |
| Calm After Storm | Range Contraction | 0.15% | |
| Earnings Movers | Other | 0.15% | |
| Down 3 Days in a Row | Weakness | 0.15% |
| Alert | Time |
|---|---|
| Possible NR7 | about 17 hours ago |
| Gap Down Partially Closed | about 21 hours ago |
| Gap Down Closed | about 21 hours ago |
| Reversed from Down | about 21 hours ago |
| Gapped Down (Partial) | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 11/13/2024
Catalent, Inc. Description
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: S&P 500 Biotechnology Biopharmaceutical Life Sciences Pharmacy Pharmacology Health Products Ophthalmic Inventory Management Clinical Services Logic Products Biologic Products Oral Products Biologic Product Respiratory Products Catalent Consumer Health Products Inventory Management Services Softgel
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 61.2 |
| 52 Week Low | 36.7387 |
| Average Volume | 1,704,927 |
| 200-Day Moving Average | 57.80 |
| 50-Day Moving Average | 59.79 |
| 20-Day Moving Average | 59.07 |
| 10-Day Moving Average | 59.19 |
| Average True Range | 0.54 |
| RSI (14) | 44.75 |
| ADX | 19.98 |
| +DI | 15.04 |
| -DI | 23.12 |
| Chandelier Exit (Long, 3 ATRs) | 58.72 |
| Chandelier Exit (Short, 3 ATRs) | 59.90 |
| Upper Bollinger Bands | 59.87 |
| Lower Bollinger Band | 58.27 |
| Percent B (%b) | 0.46 |
| BandWidth | 2.72 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.23 |
| MACD Histogram | 0.0049 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 59.56 | ||||
| Resistance 3 (R3) | 59.51 | 59.28 | 59.46 | ||
| Resistance 2 (R2) | 59.28 | 59.14 | 59.30 | 59.43 | |
| Resistance 1 (R1) | 59.14 | 59.05 | 59.21 | 59.19 | 59.40 |
| Pivot Point | 58.91 | 58.91 | 58.94 | 58.93 | 58.91 |
| Support 1 (S1) | 58.77 | 58.77 | 58.84 | 58.82 | 58.60 |
| Support 2 (S2) | 58.54 | 58.68 | 58.56 | 58.57 | |
| Support 3 (S3) | 58.40 | 58.54 | 58.54 | ||
| Support 4 (S4) | 58.45 |
